You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Esophageal Squamous Cell Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • no intervention
  • Wuhan, Hubei, China
    Renmin hosptial of Wuhan University
Jul 29, 2023

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 30, 2023

Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

Recruiting
  • Esophageal Squamous Cell Carcinoma
    • Shijiazhuang, Hebei, China
      Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
    Oct 25, 2023

    Esophageal Squamous Cell Carcinoma Trial (Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin
    • (no location specified)
    Aug 17, 2023

    Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

    Recruiting
    • Metastatic Esophageal Squamous Cell Carcinoma
    • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
    • Qingdao, Shandong, China
    • +1 more
    Nov 13, 2023

    Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with

    Not yet recruiting
    • Advanced Esophageal Squamous Carcinoma With Oligometastases
    • simultaneous with radiotherapy
    • synchronous with radiotherapy
    • (no location specified)
    Nov 16, 2023

    Esophageal Cancer, Esophageal Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (LBL-007,

    Not yet recruiting
    • Esophageal Cancer
    • +2 more
    • (no location specified)
    Aug 21, 2023

    Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma Trial in Shanghai

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • +2 more
    • LDRT+CFRT
    • +2 more
    • Shanghai, China
    • +1 more
    Aug 3, 2023

    Minimal Residual Disease, Esophageal Squamous Cell Carcinoma Trial in Guangzhou

    Not yet recruiting
    • Minimal Residual Disease
    • Esophageal Squamous Cell Carcinoma
      • Guangzhou, Guangdong, China
        Guangdong Provincial People's Hospital
      Jun 10, 2023

      Resectable Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy Trial (cadonilimab+chemo)

      Not yet recruiting
      • Resectable Esophageal Squamous Cell Carcinoma
      • Neoadjuvant Therapy
      • (no location specified)
      Apr 18, 2023

      Esophageal Squamous Cell Carcinoma Trial in Shantou (Tislelizumab)

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • Shantou, Guangdong, China
        Cancer Hospital of Shantou University Medical College
      Aug 2, 2023

      Esophageal Squamous Cell Carcinoma Trial in Shanghai (Tirelizumab, Nab paclitaxel, Carboplatin)

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • Shanghai, Shanghai, China
        Ruijin hospital, Shanghai jiaotong university school of medicine
      Nov 6, 2023

      Esophageal Squamous Cell Carcinoma Trial (LY01015, Fluorouracil, Cisplatin)

      Not yet recruiting
      • Esophageal Squamous Cell Carcinoma
      • (no location specified)
      Aug 28, 2023

      Esophageal Cancer Trial in Wuhan

      Recruiting
      • Esophageal Cancer
        • Wuhan, Hubei, China
          Renmin hosptial of Wuhan University
        Jun 7, 2023

        Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
        • (no location specified)
        Mar 17, 2023

        Esophageal Squamous Cell Carcinoma Trial in Wuhan (Intensity-modulated radiotherapy (IMRT), Tislelizumab, Cisplatin)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma
        • Intensity-modulated radiotherapy (IMRT)
        • +3 more
        • Wuhan, Hubei, China
          Renmin hosptial of Wuhan University
        Jun 16, 2023

        Esophageal Squamous Cell Carcinoma (ESCC), PD-1 Inhibitors Trial in Zhengzhou (IBI110+Sintilimab)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma (ESCC)
        • PD-1 Inhibitors
        • Zhengzhou, Henan, China
          Feng Wang
        Oct 9, 2023

        Esophageal Squamous Cell Carcinoma Trial (XH-30002 capsule, Afatiinb tablet)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma
        • XH-30002 capsule
        • Afatiinb tablet
        • (no location specified)
        Jun 25, 2023

        ctDNA-MRD in Predicting Efficacy of Esophageal Squamous Cell

        Not yet recruiting
        • Squamous Cell Carcinoma of Esophagus
          • (no location specified)
          Feb 25, 2023

          The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,

          Recruiting
          • The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
          • Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
          • Hanzhou, Zhejiang, China
            Lulu Liu
          Jul 14, 2023

          Esophageal Squamous Cell Carcinoma Trial in Nanjing (Carrelizumab, Paclitaxel injection, Cisplatin)

          Enrolling by invitation
          • Esophageal Squamous Cell Carcinoma
          • Nanjing, China
            The First Affiliated Hospital of Nanjing Medical University
          Sep 19, 2023

          Esophageal Squamous Cell Carcinoma Trial in Anyang, Zhengzhou (AK104, nab-paclitaxel, carboplatin)

          Not yet recruiting
          • Esophageal Squamous Cell Carcinoma
          • AK104, nab-paclitaxel, carboplatin
          • Anyang, Henan, China
          • +1 more
          Jun 1, 2023

          Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

          Recruiting
          • Esophageal Squamous Cell Carcinoma
          • Head and Neck Squamous Cell Carcinoma
          • Chengdu, Sichuan, China
            West China Hospital, Sichuan University
          Oct 25, 2023

          Esophageal Squamous Cell Carcinoma, Chemoradiotherapy, Immunonutrition Trial in Hefei (Whole-course Immunonutrition Combined

          Not yet recruiting
          • Esophageal Squamous Cell Carcinoma
          • +3 more
          • Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs
          • Hefei, China
            Anhui provincial hospital
          Apr 16, 2023

          Esophageal Squamous Cell Carcinoma Trial in Hangzhou (Cadonilimab combined Anlotinib)

          Recruiting
          • Esophageal Squamous Cell Carcinoma
          • Cadonilimab combined Anlotinib
          • Hangzhou, Zhejiang, China
            2nd Affiliated Hospital, School of Medicine, Zhejiang University
          Aug 6, 2023